Lundbeck says cancer drug approved in Canada
COPENHAGEN Aug 28 (Reuters) - Danish pharmaceutical group Lundbeck said on Tuesday it had received approval from Health Canada for its cancer treatment Treanda which is used to treat two common types of cancer including lymphocytic leukaemia.
Lundbeck said the move would substantially strengthen the group's growth outlook, but kept its full-year guidance intact.
It said it expected Treanda would be available to physicians and patients in Canada during September.
(Reporting by Mette Fraende; Editing by Dan Lalor)
- Tweet this
- Share this
- Digg this
- U.S. strikes have slowed Iraq militants but not weakened them - Pentagon
- Arvind Subramanian likely to be chief econ adviser
- Indians keep faith with Modi, best hope for economy - poll
- Govt raises sugar import duty to 25 pct from 15 pct
- EXCLUSIVE - Apple iPhone 6 screen snag leaves supply chain scrambling